Liefeng Ling
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Advanced Glycation End Products research
Papers in
-
- Medicinal Plants and Bioactive Compounds 3
- Circular RNAs in diseases 2
- Photosynthetic Processes and Mechanisms 2
-
- Biomarkers in Disease Mechanisms 3
- Co-authors
- Zhilin Qi (8 shared papers)Shimei Qi (6 shared papers)Jun Lv (4 shared papers)Yao Zhang (7 shared papers)Liang Yan (6 shared papers)Zunyong Feng (3 shared papers)Lei Xu (8 shared papers)Yiping Zhu (3 shared papers)
- Journals
- Molecular Biology and Evolution (1 paper)Journal of Photochemistry and Photobiology B Biology (1 paper)Journal of Biology (1 paper)Oxidative Medicine and Cellular Longevity (1 paper)International Immunopharmacology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Liefeng Ling
18 papers receiving 355 citations
Peers
Comparison fields: 5 of 77
- Cancer Research 78
- Clinical Biochemistry 22
- Pharmacology 26
- Molecular Biology 206
- Geriatrics and Gerontology 7
Countries citing papers authored by Liefeng Ling
This map shows the geographic impact of Liefeng Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liefeng Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liefeng Ling more than expected).
Fields of papers citing papers by Liefeng Ling
This network shows the impact of papers produced by Liefeng Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liefeng Ling. The network helps show where Liefeng Ling may publish in the future.
Co-authors
The 25 scholars most cited alongside Liefeng Ling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 66 | |
| 2 | 2016 | 62 | |
| 3 | 2018 | 32 | |
| 4 | 2017 | 31 | |
| 5 | 2017 | 30 | |
| 6 | 2018 | 29 | |
| 7 | 2019 | 23 | |
| 8 | 2014 | 17 | |
| 9 | 2011 | 12 | |
| 10 | 2015 | 12 | |
| 11 | 2016 | 11 | |
| 12 | 2018 | 11 | |
| 13 | 2019 | 9 | |
| 14 | 2020 | 5 | |
| 15 | 2021 | 4 | |
| 16 | [Dual role of daphnetin in suppressing HMGB1 release and HMGB1-induced inflammation in murine macrophage RAW264.7 cells and human monocytic THP-1 cells in vitro]. | 2015 | 2 |
| 17 | The effexct of green tea abstracts on p21 and p53 protein expression in human gastric carcinoma cells | 1999 | 1 |
| 18 | 2015 | 1 |
About Liefeng Ling
Liefeng Ling is a scholar working on Molecular Biology, Immunology, Pharmacology, Clinical Biochemistry and Cancer Research, having authored 18 papers that have together received 358 indexed citations. Recurring topics across this work include Biomarkers in Disease Mechanisms (3 papers), Medicinal Plants and Bioactive Compounds (3 papers), MicroRNA in disease regulation (3 papers), Cancer-related molecular mechanisms research (3 papers), Cellular transport and secretion (2 papers), Circular RNAs in diseases (2 papers), Photosynthetic Processes and Mechanisms (2 papers) and Light effects on plants (2 papers). The work is most often cited by research in Cancer Research (78 citations), Clinical Biochemistry (22 citations), Pharmacology (26 citations), Molecular Biology (206 citations) and Geriatrics and Gerontology (7 citations). Liefeng Ling has collaborated with scholars based in China and United States. Frequent co-authors include Zhilin Qi, Shimei Qi, Jun Lv, Yao Zhang, Liang Yan, Zunyong Feng, Lei Xu, Yiping Zhu, Liuwang Nie and Jinzhu Ma. Their work appears in journals such as Molecular Biology and Evolution, Journal of Photochemistry and Photobiology B Biology, Journal of Biology, Oxidative Medicine and Cellular Longevity and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.